Air & Water Borne Diseases
Open Access

Hepatitis infection; Pregnancy; Hepatitis B; Hepatitis C; Maternal health; Fetal health

Introduction

Hepatitis infections, particularly hepatitis B and hepatitis C, present unique challenges during pregnancy, necessitating a comprehensive understanding of the associated risks and effective management strategies. These viral infections can impact both maternal and fetal health, requiring a multidisciplinary approach to ensure the well-being of expectant mothers and their unborn children [1,2].

Hepatitis B and C are prevalent infections worldwide, and pregnant women with these viruses face specific concerns. Transmission of hepatitis from mother to child during childbirth is a primary risk, potentially leading to chronic hepatitis and long-term health consequences for the offspring. Furthermore, mothers with hepatitis infections may experience complications related to their own liver health during pregnancy, adding another layer of complexity to maternal care [3].

This article explores the risks associated with hepatitis infections during pregnancy and delves into the crucial strategies for their management. Emphasizing the importance of screening, monitoring, and preventive measures, we aim to provide valuable insights for healthcare providers and expectant mothers.

Understanding hepatitis infection

Hepatitis is a viral infection that affects the liver and can lead to inflammation, scarring, and, in severe cases, liver failure. Hepatitis B and hepatitis C are two common types of hepatitis that can have implications for pregnancy.

Hepatitis B in pregnancy

Hepatitis B is a viral infection caused by the hepatitis B virus (HBV). If a pregnant woman has a chronic HBV infection, there is a risk of transmitting the virus to her baby during childbirth. The risk is especially significant if the mother is also positive for the hepatitis B e-antigen (HBeAg) [4].

The transmission of hepatitis B to the newborn can lead to chronic hepatitis B, which significantly increases the risk of liver disease, cirrhosis, and liver cancer later in life. To prevent transmission, healthcare providers typically recommend two key interventions:

• Hepatitis B vaccine: Newborns are given the hepatitis B vaccine shortly after birth. This vaccine stimulates the baby's immune system to develop protection against the virus.

• Hepatitis B immune globulin (HBIG): In addition to the vaccine, newborns born to mothers with HBV should receive a dose of HBIG. This provides immediate passive immunity against hepatitis B [5].

Hepatitis C in pregnancy

Hepatitis C is caused by the hepatitis C virus (HCV). While hepatitis C transmission during childbirth is less common than with hepatitis B, it can still occur, especially if the mother has a high viral load. Management of hepatitis C in pregnancy may involve close monitoring, particularly to assess the viral load, liver function, and potential complications. The main goal is to prevent transmission to the baby and protect the mother's liver health [6].

Risks associated with hepatitis infection in pregnancy

Transmission to the Baby: The most significant risk of hepatitis infection during pregnancy is the potential transmission of the virus to the newborn. This can lead to chronic hepatitis, which may have longterm health consequences.

• Maternal health complications: Pregnant women with chronic hepatitis may experience worsening liver function during pregnancy, necessitating careful monitoring.

• Co-infection and complications: Some pregnant women may have co-infections with HIV or other sexually transmitted infections, which can complicate the management of hepatitis [7].

Management strategies

To manage hepatitis infection in pregnancy effectively, the following strategies are crucial:

• Screening and diagnosis: All pregnant women should undergo screening for hepatitis B and hepatitis C early in pregnancy.

Identifying the infection is the first step in managing it.

• Antenatal care: Women with hepatitis B and hepatitis C should receive comprehensive antenatal care, including regular monitoring of liver function and viral load.

• Vaccination and HBIG: As mentioned earlier, newborns of mothers with hepatitis B should receive the hepatitis B vaccine and HBIG to prevent transmission.

• Avoidance of high-risk behaviors: Pregnant women with hepatitis C should be counseled on avoiding high-risk behaviors, such as intravenous drug use or unprotected sex, which can increase the risk of transmission.

• Treatment considerations: The management of hepatitis during pregnancy may involve antiviral therapy in select cases. The decision to initiate treatment should be made on a case-by-case basis, carefully weighing the benefits and potential risks [8].

• Preconception planning: Women with hepatitis infection who plan to become pregnant should consult with healthcare providers to optimize their health before conception.

Discussion

The risk of transmitting hepatitis B and C from mother to child during childbirth is a primary concern. Vertical transmission can lead to chronic hepatitis in the infant, which may result in liver disease, cirrhosis, and even liver cancer later in life. Identifying and addressing these risks is pivotal to the well-being of both mother and child.

Early screening for hepatitis B and C in pregnancy is paramount. Routine screening allows for timely diagnosis and the initiation of appropriate management measures. Identifying maternal infection early in pregnancy provides an opportunity to assess the risk of transmission to the baby and tailor care accordingly [9]. Comprehensive antenatal care is essential for women with hepatitis infections. This care includes regular monitoring of liver function, viral load, and other relevant parameters to detect any changes that may require intervention. Antenatal care also provides a platform for education and counseling on preventive measures.

For pregnant women with hepatitis B, vaccination and the administration of hepatitis B immune globulin (HBIG) to newborns are key preventive measures. The hepatitis B vaccine stimulates the baby's immune system to develop protection against the virus, while HBIG provides immediate passive immunity. The management of hepatitis C in pregnancy often involves monitoring to assess the viral load, liver function, and potential complications. Pregnant women with hepatitis C should be counseled on avoiding high-risk behaviors that could increase the risk of transmission, such as intravenous drug use or unprotected sex [10].

In select cases, antiviral therapy may be considered for pregnant women with hepatitis infection. However, the decision to initiate treatment should be made on a case-by-case basis, carefully weighing the potential benefits against any associated risks to the mother and fetus. Women with hepatitis infections who plan to become pregnant should consult with healthcare providers to optimize their health before conception. This may involve discussing treatment options and ensuring viral loads are as low as possible to minimize transmission risks.

Conclusion

Hepatitis infection during pregnancy can pose significant risks to both the mother and the baby. However, with appropriate screening, monitoring, and preventive measures, the risk of transmission can be significantly reduced. It is essential for pregnant women with hepatitis to work closely with healthcare providers to ensure the best possible outcome for themselves and their newborns. Hepatitis infection does not have to be a barrier to a healthy pregnancy, but it does require vigilant management and care.

Acknowledgement

None

Conflict of Interest

None

References

1. Baïz N (2011)Maternal exposure to air pollution before and during pregnancy related to changes in newborn's cord blood lymphocyte subpopulations. The EDEN study cohort. BMC Pregnancy Childbirth 11: 87.

Indexed at Google Scholar, Crossref

2. Downs S H (2007)Reduced exposure to PM 10 and attenuated age-related decline in lung function. New Engl J Med 357: 2338-2347.

Indexed at, Google Scholar, Crossref

3. Song C (2017)Air pollution in China: status and spatiotemporal variations. Environ. Pollut 227: 334-347

Indexed at, Google Scholar, Crossref

4. Fuchs O (2017)Asthma transition from childhood into adulthood. Lancet Respir. Med 5: 224-234.

Indexed at, Google Scholar, Crossref

5. Lin HH (2008)Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factors, modeling study. Lancet 372: 1473-1483.

Indexed at, Google Scholar, Crossref

6. Kristin A (2007)Long-term exposure to air pollution and incidence of cardiovascular events in women. New Engl J Med 356: 905-913.

Indexed at, Google Scholar, Crossref

7. Gauderman WJ (2015)Association of improved air quality with lung development in children. New Engl J Med 372: 905-913.

Indexed at, Google Scholar, Crossref

8. Lelieveld J (2015)The contribution of outdoor air pollution sources to premature mortality on a global scale. Nature 525: 367-371.

Indexed at, Google Scholar, Crossref

9. Di Q. (2017)Air pollution and mortality in the medicare population. New Engl J Med 376: 2513-2522.

Indexed at, Google Scholar, Crossref

10. Christopher (2017)Preterm birth associated with maternal fine particulatematter exposure: a global, regional and national assessment. Environ Int 101: 173-182.

Indexed at, Google Scholar, Crossref